XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Restricted Stock Unit Activity The following table summarizes restricted stock unit, or RSU, activities for the three months ended March 31, 2024:
   Restricted
Stock
Units
   Weighted
Average
Grant
Date Fair
Value
 
Non-vested as of December 31, 2023   236,679   $7.07 
Granted   210,700    1.91 
Forfeited   
-
    
-
 
Vested   (104,484)   10.57 
Non-vested as of March 31, 2024   342,895   $2.84 
Schedule of Stock Option Activities The following table summarizes stock option activities for the three months ended March 31, 2024:
   Options   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding as of December 31, 2023   2,900,205   $9.50    8.03   $20 
Granted   1,102,300    1.91    
-
    
-
 
Exercised   
-
    
-
    
-
    
-
 
Forfeited   
-
    
-
    
-
    
-
 
Expired   (627)   3.20    
-
    
-
 
Outstanding as of March 31, 2024   4,001,878   $7.41    7.45   $3,675 
                     
Vested and expected to vest at March 31, 2024   4,001,878   $7.41    7.45   $3,675 
Exercisable as of March 31, 2024   1,648,715    12.90    6.71    429 
(1)Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on December 31, 2023 and March 31, 2024, respectively. The intrinsic value of options exercised during the period ended March 31, 2024 was $0 and no options were exercised.
Schedule of Total Stock-Based Compensation Costs The following tables summarize total stock-based compensation costs recognized:
   For the Three Months Ended
March 31,
 
   2024   2023 
Restricted stock units  $151   $314 
Stock options   1,075    1,261 
Total  $1,226   $1,575 
Schedule of Stock-Based Compensation Expense Stock-based compensation expense was reflected within the condensed consolidated statements of operations and comprehensive loss as:
   For the Three Months Ended
March 31,
 
   2024   2023 
Research and development  $374   $400 
General and administrative   852    1,175 
Total  $1,226   $1,575